131
Views
2
CrossRef citations to date
0
Altmetric
In Vivo Studies with Dieckol, A Potent New Radioprotector

Dieckol rescues mice from lethal irradiation by accelerating hemopoiesis and curtailing immunosuppression

, , , , , , , , & show all
Pages 848-859 | Received 04 Aug 2009, Accepted 09 Apr 2010, Published online: 01 Oct 2010
 

Abstract

Purpose: To evaluate the radioprotective effect of dieckol, a component of the brown algae Ecklonia cava.

Materials and methods: Mice were lethally irradiated, treated with dieckol and surveyed for survival and the mechanism of radioprotection.

Results: Dieckol treatment lengthened the survival of irradiated mice and significantly accelerated the hemopoietic recovery of bone marrow cells and peripheral immune cells compared with irradiated, but untreated controls. Dieckol also enhanced the proliferation and differentiation of immune cells, which had been suppressed by ionising radiation. It turned out that the increased expression of oxygen radical-scavenging enzyme manganese superoxide dismutase (MnSOD) and subsequent reduction in DNA damage and lipid peroxidation was crucial for dieckol's radioprotective effect. In addition, the dieckol-induced modulation of protein 53 (p53)-dependent pathways further strengthened the radioresistance of immune cells.

Conclusion: Dieckol can be a promising agent for reducing the time needed for reconstitution of hemopoietic cells after exposure to irradiation.

Acknowledgements

This research was performed under the program of Basic Atomic Energy Research Institute (BAERI) which is a part of the Nuclear R&D Programs funded by the Ministry of Science & Technology (MOST) of Korea grant number (2005-04732). The authors wish to thank P. Minick and T.H. Chung for editorial assistance.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.